Heart Test Laboratories, Inc. Return on Equity (ROE)
| Apr'20 | Apr'21 | Apr'22 | Apr'23 | Apr'24 | |
|---|---|---|---|---|---|
| Return on Equity (ROE) | (1,207.8%) | 307.7% | 121.2% | 218.2% | (175.0%) |
Heart Test Laboratories, Inc. (HSCS) Return on Equity (ROE) comparison analysis
General
LTM Return on Equity (ROE)
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
HSCS key stats
| Apr'20 | Apr'21 | Apr'22 | Apr'23 | Apr'24 | |
|---|---|---|---|---|---|
% growth | 0.1 0.0% | 0.0 (60.1%) | 0.0 (43.9%) | 0.0 (64.2%) | 0.0 261.2% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
% margin | 0.0 27.6% | 0.0 58.3% | 0.0 45.1% | 0.0 45.7% | 0.0 67.3% |
| Operating Expenses | 3.8 | 2.6 | 4.7 | 6.1 | 6.3 |
| Research & Development Expenses (R&D) | 2.0 | 1.7 | 3.0 | 2.5 | 2.9 |
| Selling, General & Administrative Expenses (SG&A) | 1.8 | 0.9 | 1.7 | 3.7 | 3.4 |
% margin | (3.8) (5,949.0%) | (2.6) (10,030.2%) | (4.7) (32,765.6%) | (6.1) (118,698.3%) | (6.3) (33,902.0%) |
| Interest Income | 0.0 | 0.1 | 0.4 | 0.2 | 0.0 |
| Interest Expense | 0.0 | 0.1 | 0.4 | 0.2 | 0.4 |
| Pre-tax Income | (3.8) | (2.5) | (4.8) | (6.4) | (6.6) |
% effective tax rate | 0.0 (0.6%) | 0.1 (5.3%) | (0.3) 5.2% | 484.5 (7,624.8%) | 0.0 0.0% |
% margin | (3.8) (5,973.4%) | (2.6) (10,081.1%) | (4.6) (31,851.8%) | (490.9) (9,531,151.3%) | (6.6) (35,511.9%) |
| EPS | (115.69) | (77.89) | (137.94) | (6,173.88) | (18.74) |
| Diluted EPS | (115.69) | (77.89) | (137.94) | (6,173.88) | (18.74) |
% margin | (3.7) (5,834.2%) | (2.3) (8,928.7%) | (4.4) (30,822.2%) | (6.1) (118,139.8%) | (6.2) (33,096.7%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Heart Test Laboratories, Inc.'s Return on Equity (ROE)?
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is (83,172.2%), based on the financial report for Oct 31, 2024 (Q4’2024). The average annual Return on Equity (ROE) for Heart Test Laboratories, Inc. have been (2,234.2%) over the past three years, and (1,675.6%) over the past five years.
2) Is Heart Test Laboratories, Inc.'s Return on Equity (ROE) Good?
As of today, Heart Test Laboratories, Inc.'s Return on Equity (ROE) is (83,172.2%), which is lower than industry median of (22.4%). It indicates that Heart Test Laboratories, Inc.'s Return on Equity (ROE) is Bad.